Overview

Internal Radiation Therapy After Lumpectomy in Treating Women With Ductal Carcinoma in Situ

Status:
Terminated
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Internal radiation uses radioactive material placed directly into or near a tumor to kill tumor cells. Giving internal radiation therapy using a special radiation therapy device may kill any tumor cells that remain after surgery. PURPOSE: This phase II trial is studying how well internal radiation therapy after lumpectomy works in treating women with ductal carcinoma in situ.
Phase:
Phase 2
Details
Lead Sponsor:
Masonic Cancer Center, University of Minnesota
Treatments:
Tamoxifen